TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32668833

Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block (ISB) with 15 ml of 0.5% ropivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anterior suprascapular nerve block (SSB) with 15 ml of 0.5% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Posterior suprascapular nerve block (SSB) with 15 ml of 0.5% ropivacaine
Number of subjects: 60
Study: 34134880

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE) plus methadone TAU (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Methadone TAU only (n = 15)
Number of subjects: 30
Study: 32142372

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 36166132

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 44
Study: 34419121

Group type: EXPERIMENTAL
Intervention: Incentive before questionnaire return (£15 gift voucher)
Number of subjects: 923

Group type: COMPARATOR
Intervention: Incentive after questionnaire return (£15 gift voucher)
Number of subjects: 923
Study: 32701847

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Slow-paced breathing
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham mindfulness meditation
Number of subjects: 59
Study: 36007566

Group type: EXPERIMENTAL
Intervention: Cluster 3 (young men with obesity and diabetes)
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Cluster 4 (low resting blood pressure)
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: LCA Cluster B (younger men with few comorbidities)
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: LCA Cluster C (older individuals with AF and renal impairment)
Number of subjects: 812
Study: 32697858

Group type: EXPERIMENTAL
Intervention: Autophagy-activating peptide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 35112011

Group type: EXPERIMENTAL
Intervention: ReDeSign online dementia training program (n = 62)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (n = 62)
Number of subjects: 124
Study: 32388198

Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF
Number of subjects: 1265

Group type: COMPARATOR
Intervention: Sputum AFB smear
Number of subjects: 1265
Study: 36367711

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 14
Study: 33693907

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (injectable testosterone undecanoate)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 601
Study: 32610640

Group type: EXPERIMENTAL
Intervention: Be a Mom (web-based self-guided intervention)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 367
Study: 36027670

Group type: EXPERIMENTAL
Intervention: Femistina (40 mg, oral, twice daily for 20 days)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Canephron (3 × 5 ml taken orally three times daily for 4 weeks)
Number of subjects: 320
Study: 34022636

Group type: EXPERIMENTAL
Intervention: Fixed dose of 4-factor prothrombin complex concentrate (4FPCC) at 1500 IU
Number of subjects: 71

Group type: COMPARATOR
Intervention: Variable dosing of 4-factor prothrombin complex concentrate (4FPCC)
Number of subjects: 71
Study: 32662200

Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fruit juice
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sugar cubes
Number of subjects: 32
Study: 34379122

Group type: EXPERIMENTAL
Intervention: SUPA intervention utilizing cognitive behavioral and motivational interviewing techniques
Number of subjects: 0
Study: 34404144

Group type: EXPERIMENTAL
Intervention: Micro-implant assisted rapid palatal expansion (MARPE) in fusion group
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Micro-implant assisted rapid palatal expansion (MARPE) in non-fusion group
Number of subjects: 28
Study: 34285004

Group type: COMPARATOR
Intervention: Antibiotics (penicillins, cephalosporins, macrolides)
Number of subjects: 432
Study: 32916306

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transfer (FMT) from post-Roux-en-Y gastric bypass (RYGB) donors
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral butyrate supplementation
Number of subjects: 24
Study: 35081440

Group type: EXPERIMENTAL
Intervention: XP-endo Shaper (XPS) with 10 pecking motions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RB) with 4 pecking motions
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: WaveOne Gold (WOG) with 4 pecking motions
Number of subjects: 45
Study: 34649825

Group type: COMPARATOR
Intervention: Resistance Training (RT)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Aerobic Training (AT)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 248
Study: 35071600

Group type: EXPERIMENTAL
Intervention: MitoQ (20 mg/day, oral)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET) (cycle ergometer, moderate intensity, 40-60% VO2 peak, heart rate 120-140 b/min, 45 min a day, three days/week for six weeks)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: MitoQ + ET
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33849510

Group type: EXPERIMENTAL
Intervention: Visual mapping techniques (mind mapping & concept mapping) after each community-based teaching session
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional method (Question-Answer session with built-in discussion)
Number of subjects: 60
Study: 33472786

Group type: EXPERIMENTAL
Intervention: Motor control exercises
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Graded activity
Number of subjects: 414
Study: 33371104

Group type: EXPERIMENTAL
Intervention: Whitacre needle
Number of subjects: 164

Group type: COMPARATOR
Intervention: Chiba needle
Number of subjects: 164
Study: 35946246

Group type: EXPERIMENTAL
Intervention: tell‐show‐play‐doh
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Playmobil Dentist
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: mobile dentist games
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: role play as dentist
Number of subjects: 125

Group type: COMPARATOR
Intervention: tell‐show‐do
Number of subjects: 125
Study: 32584091

Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment (MBT)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Structured clinical management (SCM)
Number of subjects: 134
Study: 32920164

Group type: EXPERIMENTAL
Intervention: CBT-based mobile application (4 min daily exercises for two weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 90
Study: 36174627

Group type: EXPERIMENTAL
Intervention: Adjuvant S-1 plus endocrine therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33621782

Group type: EXPERIMENTAL
Intervention: Peer-Led Self-Management (PLSM) program for 4 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group received a self-management manual and usual clinical care
Number of subjects: 28
Study: 32150151

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (atDCS) over S1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (ctDCS) over M1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS (stDCS) over M1
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham tDCS (stDCS) over S1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (atDCS) over M1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (ctDCS) over S1
Number of subjects: 30
Study: 32546430

Group type: EXPERIMENTAL
Intervention: Newborn screening (NBS) group, 57 subjects
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group, 47 subjects
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 104
Study: 32499312

Group type: EXPERIMENTAL
Intervention: Highest quintile of Empirical Dietary Index for Hyperinsulinemia (EDIH)
Number of subjects: 1024
Study: 34813901

Group type: EXPERIMENTAL
Intervention: Nutritional supplement (20 g whey protein + 800 IU vitamin D)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Physical activity (brisk walking, muscle-strengthening exercises for lower limbs, balance training)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 33894365

Group type: EXPERIMENTAL
Intervention: Interscalene nerve block (INB)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Local liposomal bupivacaine (LLB)
Number of subjects: 108
Study: 32585263

Group type: EXPERIMENTAL
Intervention: Selective caries removal to soft dentin (SCRSD)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Stepwise excavation (SW)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Amalgam (AM)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Resin composite (RC)
Number of subjects: 172
Study: 36114020

Group type: EXPERIMENTAL
Intervention: ARRY-371797 (PF-07265803)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 8
Study: 35777413

Group type: EXPERIMENTAL
Intervention: [18F]FDG-PET-CT
Number of subjects: 147

Group type: COMPARATOR
Intervention: CT
Number of subjects: 147
Study: 36254014

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal saline (CON group)
Number of subjects: 54
Study: 33984536

Group type: EXPERIMENTAL
Intervention: Low frequency nrTMS (1 Hz, 15 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 32612085

Group type: EXPERIMENTAL
Intervention: Evening-only low-carbohydrate meal (LCM) at 1800 h
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard test meals (STMs)
Number of subjects: 14
Study: 33735416

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg BID for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 33253294

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 48389

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 48389

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 48389

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 48389
Study: 33423990

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) applied for 5 weeks, one session per week
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low-level laser therapy (LLLT) applied with 15 sessions on consecutive days
Number of subjects: 52
Study: 35487860

Group type: EXPERIMENTAL
Intervention: Intervention (INT): Reduced sedentary behavior by 50 min/day
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (CON): Maintained baseline activity levels
Number of subjects: 64
Study: 34144031

Group type: EXPERIMENTAL
Intervention: SexHealth intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Printed materials (control)
Number of subjects: 91
Study: 35578655

Group type: EXPERIMENTAL
Intervention: Interactively controllable graphics on the spread of COVID-19 and information on physical distancing
Number of subjects: 817

Group type: COMPARATOR
Intervention: Text-based information about quantitative evidence
Number of subjects: 817
Study: 35976021

Group type: EXPERIMENTAL
Intervention: Tapinarof 1% cream applied once daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 33498159

Group type: EXPERIMENTAL
Intervention: Aggressive treatment at both metastatic and primary sites (Group A)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Non-aggressive treatment (Group B)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Patients not treated with PD-L1 inhibitors
Number of subjects: 67
Study: 35459599

Group type: EXPERIMENTAL
Intervention: Low-level laser acupuncture (LA)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 82
Study: 33000439

Group type: EXPERIMENTAL
Intervention: Sexually arousing film clip
Number of subjects: 90

Group type: COMPARATOR
Intervention: Emotionally neutral film clip
Number of subjects: 90
Study: 35266589

Group type: EXPERIMENTAL
Intervention: TXA 15 mg/kg bolus dose, followed by 2 mg/kg/hr infusion over 8 hours
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: TXA 30 mg/kg bolus dose, followed by 4 mg/kg/hr infusion over 8 hours
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal saline placebo bolus and infusion
Number of subjects: 31
Study: 34031759

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Clarithromycin-hydroxychloroquine
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 34040108

Group type: EXPERIMENTAL
Intervention: JNJ-61803534 (oral formulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: JNJ-61803534 (in mouse models)
Number of subjects: 0
Study: 35316429

Group type: EXPERIMENTAL
Intervention: Individualized nursing intervention based on a comprehensive geriatric assessment (CGA)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 92
Study: 32009005

Group type: EXPERIMENTAL
Intervention: Twin block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trigger point injections
Number of subjects: 40
Study: 34537829

Group type: EXPERIMENTAL
Intervention: salvinorin-A
Number of subjects: 2

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2
Study: 32306100

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group (CT) - Stretching exercises
Number of subjects: 20
Study: 96005583

Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 10
Study: 33705531

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 30507

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 30507
Study: 32143828

Group type: EXPERIMENTAL
Intervention: Hydrus Microstent (HMS)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Cataract surgery alone (no microstent [NMS])
Number of subjects: 556
Study: 35954850

Group type: EXPERIMENTAL
Intervention: Psychodynamic psychotherapy treatment over 28 sessions
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Feeling-Word Checklist-28 (FWC-28)
Number of subjects: 62
Study: 33252075

Group type: EXPERIMENTAL
Intervention: Verubecestat
Number of subjects: 1785

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1785
Study: 35943788

Group type: EXPERIMENTAL
Intervention: Customization of the AirHeart app (personalizing a virtual avatar and travel vehicle)
Number of subjects: 94

Group type: COMPARATOR
Intervention: No customization of the AirHeart app
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: AirHeart app features (journaling, mood tracking, reminders)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Avatar identification
Number of subjects: 94
Study: 33904295

Group type: EXPERIMENTAL
Intervention: Short course antibiotics (1g of ceftriaxone with 500mg of metronidazole stat post umbilical cord clamping)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Long course antibiotics (post-operative doses of intravenous ceftriaxone 1g 12 hourly with 500mg of metronidazole eight hourly for 24 hours, then oral cefuroxime 500mg twice daily and metronidazole 400mg thrice daily for five days)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Short course antibiotics
Number of subjects: 166

Group type: COMPARATOR
Intervention: Long course antibiotics
Number of subjects: 166
Study: 35717403

Group type: EXPERIMENTAL
Intervention: PETReA trial during COVID-19
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Collaborative discussions about risks and benefits of randomisation
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Trial communication strategies
Number of subjects: 41
Study: 34689847

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids from flaxseed oil
Number of subjects: 0
Study: 35561440

Group type: COMPARATOR
Intervention: Olfactory home test using household items
Number of subjects: 50

Group type: COMPARATOR
Intervention: CPS-C(de)
Number of subjects: 50
Study: 32054483

Group type: EXPERIMENTAL
Intervention: Wharton's jelly formulation
Number of subjects: 0
Study: 34030555

Group type: EXPERIMENTAL
Intervention: BDP 200 µg BID
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: BDP 50 µg BID
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: BDP 400 µg BID
Number of subjects: 610

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: QVAR® 160 µg BID
Number of subjects: 610
Study: 34276328

Group type: EXPERIMENTAL
Intervention: Active VNS stimulation (2–5 mA, once a week for 1 hour for 12 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dummy stimulation (same parameters as active VNS but at an irrelevant anatomical site)
Number of subjects: 120
Study: 35956333

Group type: EXPERIMENTAL
Intervention: Dietitian-led behavior counselling sessions
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Lowest lean mass index z-score at 9 months
Number of subjects: 101

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 101
Study: 33634478

Group type: EXPERIMENTAL
Intervention: Reduced-dose facilitated PCI strategy (reduced-dose fibrinolysis combined with simultaneous transfer for immediate invasive therapy with a time interval between fibrinolysis to PCI < 3 hours)
Number of subjects: 632

Group type: COMPARATOR
Intervention: Standard pharmacoinvasive treatment
Number of subjects: 632
Study: 34908192

Group type: EXPERIMENTAL
Intervention: Nalbuphine ER
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 33257178

Group type: EXPERIMENTAL
Intervention: Stepping Stones and Creating Futures intervention
Number of subjects: 674

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 674
Study: 34709497

Group type: EXPERIMENTAL
Intervention: HS016
Number of subjects: 0

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 0
Study: 33392835

Group type: EXPERIMENTAL
Intervention: Abemaciclib + endocrine therapy (ET)
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Placebo + endocrine therapy (ET)
Number of subjects: 1152

Group type: EXPERIMENTAL
Intervention: Abemaciclib + ET
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Placebo + ET
Number of subjects: 1152
Study: 32876791

Group type: EXPERIMENTAL
Intervention: Ice wrap
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Subacromial injection
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 37057581

Group type: EXPERIMENTAL
Intervention: Chamomile vaginal gel 5%
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Conjugated estrogen vaginal cream
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo vaginal gel
Number of subjects: 96
Study: 33970291

Group type: EXPERIMENTAL
Intervention: Legal, prescribed cannabis
Number of subjects: 678
Study: 34032739

Group type: EXPERIMENTAL
Intervention: On-demand treatment with nonacog alfa
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with nonacog alfa
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Overall safety of nonacog alfa
Number of subjects: 70
Study: 32583300

Group type: EXPERIMENTAL
Intervention: Aprepitant and transdermal scopolamine preoperatively followed by ondansetron and dexamethasone intraoperatively, with total intravenous anesthesia.
Number of subjects: 83

Group type: COMPARATOR
Intervention: Inhalational anesthetic and two intraoperative antiemetics without preoperative prophylaxis.
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intervention group (aprepitant and transdermal scopolamine)
Number of subjects: 83
Study: 35202361

Group type: EXPERIMENTAL
Intervention: Bonded amalgam sealants (BAS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional resin‐based sealant (RBS)
Number of subjects: 38
Study: 33216048

Group type: EXPERIMENTAL
Intervention: Grape vinegar and rose water solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash
Number of subjects: 60
Study: 34599744

Group type: EXPERIMENTAL
Intervention: ART + Brix3000™
Number of subjects: 20

Group type: COMPARATOR
Intervention: ART (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (ART + Brix3000™ and ART)
Number of subjects: 20
Study: 32023809

Group type: EXPERIMENTAL
Intervention: 10,000 IU vitamin D3 supplementation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5000 IU vitamin D3 supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 20
Study: 35120505

Group type: EXPERIMENTAL
Intervention: Theory-based education (3 training sessions of 60 to 90 minutes)
Number of subjects: 71
Study: 33754809

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 or 25 mg
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study: 33050893

Group type: EXPERIMENTAL
Intervention: Theory of planned behavior (TPB) based oral health education consisting of four one-hour training sessions over 1 week.
Number of subjects: 356

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 356
Study: 36078441

Group type: EXPERIMENTAL
Intervention: Dietary intervention designed with Behavior Change Wheel (BCW)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General dietary management (control group)
Number of subjects: 60
Study: 34801714

Group type: EXPERIMENTAL
Intervention: Tafenoquine 200 mg weekly
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 34097713

Group type: EXPERIMENTAL
Intervention: 0.75 mg ml‐1 S‐ketamine in oxycodone PCA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.5 mg ml‐1 S‐ketamine in oxycodone PCA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.25 mg ml‐1 S‐ketamine in oxycodone PCA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oxycodone alone
Number of subjects: 100
Study: 33731164

Group type: EXPERIMENTAL
Intervention: Vancomycin (powder, 1 g) applied before water-tight closure of the joint capsule
Number of subjects: 2024

Group type: COMPARATOR
Intervention: Historical control group (no vancomycin)
Number of subjects: 2024
Study: 33067287

Group type: EXPERIMENTAL
Intervention: Stand-alone VR (6-week, internet-based intervention with weekly online sessions and daily exercises)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Blended VR (same intervention supplemented with physiotherapy support)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 202